600267.SS · 海正药业
China A-shares · RS rating 88 · As of 2026-10-14
| Price | 11.36 CNY |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 88 / 67 / 72 / 77 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 34 / 36 / 40 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -9.0% |
| Distance from 52-week high | +20.9% |
| Market cap (USD) | $2.1B |